半固形剤フォームのグローバル市場 2021年：企業別、地域別、種類・用途別

• 英文タイトル：Global Semisolid Dosage Form Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-203B04036 • 出版社/出版日：GlobalInfoResearch / 2021年12月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、122ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：化学＆材料

• 販売価格（消費税別）

Single User	￥487,200 (USD3,480)	▷ お問い合わせ
Multi User	￥730,800 (USD5,220)	▷ お問い合わせ
Corporate User	￥974,400 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

半固形剤フォーム市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 GlobalInfoResearchの最新の調査によると、世界の半固形剤フォームの市場規模は2020年のxxx米ドルから2021年にはxxx米ドルと推定され、2020年から2021年の間にxxx％の変化があります。世界の半固形剤フォームの市場規模は次の5年間でxxx％のCAGRで成長すると予想されます。 半固形剤フォーム市場は種類と用途によって区分されます。2016年～2026年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメントは次をカバーします。 ・軟膏、ペースト、絆創膏、ジェル、硬質フォーム 用途別セグメントは次のように区分されます。 ・皮膚、鼻腔、膣腔、直腸腔、その他 世界の半固形剤フォーム市場の主要な市場プレーヤーは以下のとおりです。 ・Johnson & Johnson、Merck & Co、Bayer AG、Hisamitsu Pharmaceutical、Glenmark Pharmaceuticals、Cipla Ltd、Nestlé SA、Novartis AG、GlaxoSmithKline plc、Bausch Health Companies、Allergan、Biofrontera, Inc.、Crown Laboratories Inc.、Akorn Inc. (US)、Ingenus Pharmaceuticals、Sun Pharmaceuticals、Crescita Therapeutics Inc.、Mylan N.V.、Encore Dermatology, Inc.、LEO Pharma、Almirall, S.A、Aclaris Therapeutics, Inc.、Taro Pharmaceutical Industries Ltd.、Teligent Pharma、Perrigo Pharma 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計14章あります。 ・第1章では、半固形剤フォーム製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要な半固形剤フォームメーカーの企業概要、2019年～2021年までの半固形剤フォームの価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要な半固形剤フォームメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2016年～2026年までの地域別半固形剤フォームの販売量、売上、成長性を示しています。 ・第5、6章では、2016年～2026年までの半固形剤フォームの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2016年～2021年までの世界の主要国での販売量、売上、市場シェア、並びに2021年～2026年までの主要地域での半固形剤フォーム市場予測を収録しています。 ・第12、13、14章では、半固形剤フォームの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 ・メーカー情報（企業概要、製品概要、販売量、価格、売上）：Johnson & Johnson、Merck & Co、Bayer AG、Hisamitsu Pharmaceutical、Glenmark Pharmaceuticals、Cipla Ltd、Nestlé SA、Novartis AG、GlaxoSmithKline plc、Bausch Health Companies、Allergan、Biofrontera, Inc.、Crown Laboratories Inc.、Akorn Inc. (US)、Ingenus Pharmaceuticals、Sun Pharmaceuticals、Crescita Therapeutics Inc.、Mylan N.V.、Encore Dermatology, Inc.、LEO Pharma、Almirall, S.A、Aclaris Therapeutics, Inc.、Taro Pharmaceutical Industries Ltd.、Teligent Pharma、Perrigo Pharma ・メーカー別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：軟膏、ペースト、絆創膏、ジェル、硬質フォーム ・用途別分析2016年-2026年：皮膚、鼻腔、膣腔、直腸腔、その他 ・半固形剤フォームの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・半固形剤フォームのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・半固形剤フォームのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・半固形剤フォームの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・半固形剤フォームの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Semisolid Dosage Form market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Semisolid Dosage Form size is estimated to be million in 2021 from USD million in 2020, with a change of % between 2020 and 2021. The global Semisolid Dosage Form market size is expected to grow at a CAGR of % for the next five years.

Market segmentation
Semisolid Dosage Form market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Ointments
Pastes
Plasters
Gels
Rigid Foams

Market segment by Application can be divided into
Skin
Nasal Cavity
Vaginal Cavity
Rectal Cavity
Others

The key market players for global Semisolid Dosage Form market are listed below:
Johnson & Johnson
Merck & Co
Bayer AG
Hisamitsu Pharmaceutical
Glenmark Pharmaceuticals
Cipla Ltd
Nestlé SA
Novartis AG
GlaxoSmithKline plc
Bausch Health Companies
Allergan
Biofrontera, Inc.
Crown Laboratories Inc.
Akorn Inc. (US)
Ingenus Pharmaceuticals
Sun Pharmaceuticals
Crescita Therapeutics Inc.
Mylan N.V.
Encore Dermatology, Inc.
LEO Pharma
Almirall, S.A
Aclaris Therapeutics, Inc.
Taro Pharmaceutical Industries Ltd.
Teligent Pharma
Perrigo Pharma

Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Semisolid Dosage Form product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Semisolid Dosage Form, with price, sales, revenue and global market share of Semisolid Dosage Form from 2019 to 2021.
Chapter 3, the Semisolid Dosage Form competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Semisolid Dosage Form breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Semisolid Dosage Form market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Semisolid Dosage Form sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

---

1 Market Overview
1.1 Semisolid Dosage Form Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Semisolid Dosage Form Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Ointments
1.2.3 Pastes
1.2.4 Plasters
1.2.5 Gels
1.2.6 Rigid Foams
1.3 Market Analysis by Application
1.3.1 Overview: Global Semisolid Dosage Form Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Skin
1.3.3 Nasal Cavity
1.3.4 Vaginal Cavity
1.3.5 Rectal Cavity
1.3.6 Others
1.4 Global Semisolid Dosage Form Market Size & Forecast
1.4.1 Global Semisolid Dosage Form Sales in Value (2016-2026))
1.4.2 Global Semisolid Dosage Form Sales in Volume (2016-2026)
1.4.3 Global Semisolid Dosage Form Price by Type (2016-2026) & (US$/Ton)
1.5 Global Semisolid Dosage Form Production Capacity Analysis
1.5.1 Global Semisolid Dosage Form Total Production Capacity (2016-2026)
1.5.2 Global Semisolid Dosage Form Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Semisolid Dosage Form Market Drivers
1.6.2 Semisolid Dosage Form Market Restraints
1.6.3 Semisolid Dosage Form Trends Analysis
2 Manufacturers Profiles
2.1 Johnson & Johnson
2.1.1 Johnson & Johnson Details
2.1.2 Johnson & Johnson Major Business
2.1.3 Johnson & Johnson Semisolid Dosage Form Product and Services
2.1.4 Johnson & Johnson Semisolid Dosage Form Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Merck & Co
2.2.1 Merck & Co Details
2.2.2 Merck & Co Major Business
2.2.3 Merck & Co Semisolid Dosage Form Product and Services
2.2.4 Merck & Co Semisolid Dosage Form Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Bayer AG
2.3.1 Bayer AG Details
2.3.2 Bayer AG Major Business
2.3.3 Bayer AG Semisolid Dosage Form Product and Services
2.3.4 Bayer AG Semisolid Dosage Form Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Hisamitsu Pharmaceutical
2.4.1 Hisamitsu Pharmaceutical Details
2.4.2 Hisamitsu Pharmaceutical Major Business
2.4.3 Hisamitsu Pharmaceutical Semisolid Dosage Form Product and Services
2.4.4 Hisamitsu Pharmaceutical Semisolid Dosage Form Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Glenmark Pharmaceuticals
2.5.1 Glenmark Pharmaceuticals Details
2.5.2 Glenmark Pharmaceuticals Major Business
2.5.3 Glenmark Pharmaceuticals Semisolid Dosage Form Product and Services
2.5.4 Glenmark Pharmaceuticals Semisolid Dosage Form Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Cipla Ltd
2.6.1 Cipla Ltd Details
2.6.2 Cipla Ltd Major Business
2.6.3 Cipla Ltd Semisolid Dosage Form Product and Services
2.6.4 Cipla Ltd Semisolid Dosage Form Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Nestlé SA
2.7.1 Nestlé SA Details
2.7.2 Nestlé SA Major Business
2.7.3 Nestlé SA Semisolid Dosage Form Product and Services
2.7.4 Nestlé SA Semisolid Dosage Form Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Novartis AG
2.8.1 Novartis AG Details
2.8.2 Novartis AG Major Business
2.8.3 Novartis AG Semisolid Dosage Form Product and Services
2.8.4 Novartis AG Semisolid Dosage Form Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 GlaxoSmithKline plc
2.9.1 GlaxoSmithKline plc Details
2.9.2 GlaxoSmithKline plc Major Business
2.9.3 GlaxoSmithKline plc Semisolid Dosage Form Product and Services
2.9.4 GlaxoSmithKline plc Semisolid Dosage Form Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 Bausch Health Companies
2.10.1 Bausch Health Companies Details
2.10.2 Bausch Health Companies Major Business
2.10.3 Bausch Health Companies Semisolid Dosage Form Product and Services
2.10.4 Bausch Health Companies Semisolid Dosage Form Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.11 Allergan
2.11.1 Allergan Details
2.11.2 Allergan Major Business
2.11.3 Allergan Semisolid Dosage Form Product and Services
2.11.4 Allergan Semisolid Dosage Form Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.12 Biofrontera, Inc.
2.12.1 Biofrontera, Inc. Details
2.12.2 Biofrontera, Inc. Major Business
2.12.3 Biofrontera, Inc. Semisolid Dosage Form Product and Services
2.12.4 Biofrontera, Inc. Semisolid Dosage Form Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.13 Crown Laboratories Inc.
2.13.1 Crown Laboratories Inc. Details
2.13.2 Crown Laboratories Inc. Major Business
2.13.3 Crown Laboratories Inc. Semisolid Dosage Form Product and Services
2.13.4 Crown Laboratories Inc. Semisolid Dosage Form Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.14 Akorn Inc. (US)
2.14.1 Akorn Inc. (US) Details
2.14.2 Akorn Inc. (US) Major Business
2.14.3 Akorn Inc. (US) Semisolid Dosage Form Product and Services
2.14.4 Akorn Inc. (US) Semisolid Dosage Form Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.15 Ingenus Pharmaceuticals
2.15.1 Ingenus Pharmaceuticals Details
2.15.2 Ingenus Pharmaceuticals Major Business
2.15.3 Ingenus Pharmaceuticals Semisolid Dosage Form Product and Services
2.15.4 Ingenus Pharmaceuticals Semisolid Dosage Form Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.16 Sun Pharmaceuticals
2.16.1 Sun Pharmaceuticals Details
2.16.2 Sun Pharmaceuticals Major Business
2.16.3 Sun Pharmaceuticals Semisolid Dosage Form Product and Services
2.16.4 Sun Pharmaceuticals Semisolid Dosage Form Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.17 Crescita Therapeutics Inc.
2.17.1 Crescita Therapeutics Inc. Details
2.17.2 Crescita Therapeutics Inc. Major Business
2.17.3 Crescita Therapeutics Inc. Semisolid Dosage Form Product and Services
2.17.4 Crescita Therapeutics Inc. Semisolid Dosage Form Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.18 Mylan N.V.
2.18.1 Mylan N.V. Details
2.18.2 Mylan N.V. Major Business
2.18.3 Mylan N.V. Semisolid Dosage Form Product and Services
2.18.4 Mylan N.V. Semisolid Dosage Form Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.19 Encore Dermatology, Inc.
2.19.1 Encore Dermatology, Inc. Details
2.19.2 Encore Dermatology, Inc. Major Business
2.19.3 Encore Dermatology, Inc. Semisolid Dosage Form Product and Services
2.19.4 Encore Dermatology, Inc. Semisolid Dosage Form Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.20 LEO Pharma
2.20.1 LEO Pharma Details
2.20.2 LEO Pharma Major Business
2.20.3 LEO Pharma Semisolid Dosage Form Product and Services
2.20.4 LEO Pharma Semisolid Dosage Form Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.21 Almirall, S.A
2.21.1 Almirall, S.A Details
2.21.2 Almirall, S.A Major Business
2.21.3 Almirall, S.A Semisolid Dosage Form Product and Services
2.21.4 Almirall, S.A Semisolid Dosage Form Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.22 Aclaris Therapeutics, Inc.
2.22.1 Aclaris Therapeutics, Inc. Details
2.22.2 Aclaris Therapeutics, Inc. Major Business
2.22.3 Aclaris Therapeutics, Inc. Semisolid Dosage Form Product and Services
2.22.4 Aclaris Therapeutics, Inc. Semisolid Dosage Form Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.23 Taro Pharmaceutical Industries Ltd.
2.23.1 Taro Pharmaceutical Industries Ltd. Details
2.23.2 Taro Pharmaceutical Industries Ltd. Major Business
2.23.3 Taro Pharmaceutical Industries Ltd. Semisolid Dosage Form Product and Services
2.23.4 Taro Pharmaceutical Industries Ltd. Semisolid Dosage Form Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.24 Teligent Pharma
2.24.1 Teligent Pharma Details
2.24.2 Teligent Pharma Major Business
2.24.3 Teligent Pharma Semisolid Dosage Form Product and Services
2.24.4 Teligent Pharma Semisolid Dosage Form Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.25 Perrigo Pharma
2.25.1 Perrigo Pharma Details
2.25.2 Perrigo Pharma Major Business
2.25.3 Perrigo Pharma Semisolid Dosage Form Product and Services
2.25.4 Perrigo Pharma Semisolid Dosage Form Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Semisolid Dosage Form Sales by Manufacturer
3.1 Global Semisolid Dosage Form Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Semisolid Dosage Form Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Semisolid Dosage Form
3.4 Market Concentration Rate
3.4.1 Top 3 Semisolid Dosage Form Manufacturer Market Share
3.4.2 Top 6 Semisolid Dosage Form Manufacturer Market Share
3.5 Global Semisolid Dosage Form Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Semisolid Dosage Form Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Semisolid Dosage Form Market Size by Region
4.1.1 Global Semisolid Dosage Form Sales in Volume by Region (2016-2026)
4.1.2 Global Semisolid Dosage Form Revenue by Region (2016-2026)
4.2 North America Semisolid Dosage Form Revenue (2016-2026)
4.3 Europe Semisolid Dosage Form Revenue (2016-2026)
4.4 Asia-Pacific Semisolid Dosage Form Revenue (2016-2026)
4.5 South America Semisolid Dosage Form Revenue (2016-2026)
4.6 Middle East and Africa Semisolid Dosage Form Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Semisolid Dosage Form Sales in Volume by Type (2016-2026)
5.2 Global Semisolid Dosage Form Revenue by Type (2016-2026)
5.3 Global Semisolid Dosage Form Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Semisolid Dosage Form Sales in Volume by Application (2016-2026)
6.2 Global Semisolid Dosage Form Revenue by Application (2016-2026)
6.3 Global Semisolid Dosage Form Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Semisolid Dosage Form Sales by Type (2016-2026)
7.2 North America Semisolid Dosage Form Sales by Application (2016-2026)
7.3 North America Semisolid Dosage Form Market Size by Country
7.3.1 North America Semisolid Dosage Form Sales in Volume by Country (2016-2026)
7.3.2 North America Semisolid Dosage Form Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Semisolid Dosage Form Sales by Type (2016-2026)
8.2 Europe Semisolid Dosage Form Sales by Application (2016-2026)
8.3 Europe Semisolid Dosage Form Market Size by Country
8.3.1 Europe Semisolid Dosage Form Sales in Volume by Country (2016-2026)
8.3.2 Europe Semisolid Dosage Form Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Semisolid Dosage Form Sales by Type (2016-2026)
9.2 Asia-Pacific Semisolid Dosage Form Sales by Application (2016-2026)
9.3 Asia-Pacific Semisolid Dosage Form Market Size by Region
9.3.1 Asia-Pacific Semisolid Dosage Form Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Semisolid Dosage Form Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Semisolid Dosage Form Sales by Type (2016-2026)
10.2 South America Semisolid Dosage Form Sales by Application (2016-2026)
10.3 South America Semisolid Dosage Form Market Size by Country
10.3.1 South America Semisolid Dosage Form Sales in Volume by Country (2016-2026)
10.3.2 South America Semisolid Dosage Form Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Semisolid Dosage Form Sales by Type (2016-2026)
11.2 Middle East & Africa Semisolid Dosage Form Sales by Application (2016-2026)
11.3 Middle East & Africa Semisolid Dosage Form Market Size by Country
11.3.1 Middle East & Africa Semisolid Dosage Form Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Semisolid Dosage Form Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Semisolid Dosage Form Typical Distributors
12.3 Semisolid Dosage Form Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

List of Tables
Table 1. Global Semisolid Dosage Form Revenue by Type, (USD Million), 2021-2026
Table 2. Global Semisolid Dosage Form Revenue by Application, (USD Million), 2021-2026
Table 3. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 4. Johnson & Johnson Major Business
Table 5. Johnson & Johnson Semisolid Dosage Form Product and Services
Table 6. Johnson & Johnson Semisolid Dosage Form Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Merck & Co Basic Information, Manufacturing Base and Competitors
Table 8. Merck & Co Major Business
Table 9. Merck & Co Semisolid Dosage Form Product and Services
Table 10. Merck & Co Semisolid Dosage Form Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Bayer AG Basic Information, Manufacturing Base and Competitors
Table 12. Bayer AG Major Business
Table 13. Bayer AG Semisolid Dosage Form Product and Services
Table 14. Bayer AG Semisolid Dosage Form Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Hisamitsu Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 16. Hisamitsu Pharmaceutical Major Business
Table 17. Hisamitsu Pharmaceutical Semisolid Dosage Form Product and Services
Table 18. Hisamitsu Pharmaceutical Semisolid Dosage Form Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Glenmark Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 20. Glenmark Pharmaceuticals Major Business
Table 21. Glenmark Pharmaceuticals Semisolid Dosage Form Product and Services
Table 22. Glenmark Pharmaceuticals Semisolid Dosage Form Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Cipla Ltd Basic Information, Manufacturing Base and Competitors
Table 24. Cipla Ltd Major Business
Table 25. Cipla Ltd Semisolid Dosage Form Product and Services
Table 26. Cipla Ltd Semisolid Dosage Form Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Nestlé SA Basic Information, Manufacturing Base and Competitors
Table 28. Nestlé SA Major Business
Table 29. Nestlé SA Semisolid Dosage Form Product and Services
Table 30. Nestlé SA Semisolid Dosage Form Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 32. Novartis AG Major Business
Table 33. Novartis AG Semisolid Dosage Form Product and Services
Table 34. Novartis AG Semisolid Dosage Form Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. GlaxoSmithKline plc Basic Information, Manufacturing Base and Competitors
Table 36. GlaxoSmithKline plc Major Business
Table 37. GlaxoSmithKline plc Semisolid Dosage Form Product and Services
Table 38. GlaxoSmithKline plc Semisolid Dosage Form Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Bausch Health Companies Basic Information, Manufacturing Base and Competitors
Table 40. Bausch Health Companies Major Business
Table 41. Bausch Health Companies Semisolid Dosage Form Product and Services
Table 42. Bausch Health Companies Semisolid Dosage Form Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Allergan Basic Information, Manufacturing Base and Competitors
Table 44. Allergan Major Business
Table 45. Allergan Semisolid Dosage Form Product and Services
Table 46. Allergan Semisolid Dosage Form Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Biofrontera, Inc. Basic Information, Manufacturing Base and Competitors
Table 48. Biofrontera, Inc. Major Business
Table 49. Biofrontera, Inc. Semisolid Dosage Form Product and Services
Table 50. Biofrontera, Inc. Semisolid Dosage Form Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Crown Laboratories Inc. Basic Information, Manufacturing Base and Competitors
Table 52. Crown Laboratories Inc. Major Business
Table 53. Crown Laboratories Inc. Semisolid Dosage Form Product and Services
Table 54. Crown Laboratories Inc. Semisolid Dosage Form Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Akorn Inc. (US) Basic Information, Manufacturing Base and Competitors
Table 56. Akorn Inc. (US) Major Business
Table 57. Akorn Inc. (US) Semisolid Dosage Form Product and Services
Table 58. Akorn Inc. (US) Semisolid Dosage Form Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 59. Ingenus Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 60. Ingenus Pharmaceuticals Major Business
Table 61. Ingenus Pharmaceuticals Semisolid Dosage Form Product and Services
Table 62. Ingenus Pharmaceuticals Semisolid Dosage Form Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 63. Sun Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 64. Sun Pharmaceuticals Major Business
Table 65. Sun Pharmaceuticals Semisolid Dosage Form Product and Services
Table 66. Sun Pharmaceuticals Semisolid Dosage Form Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 67. Crescita Therapeutics Inc. Basic Information, Manufacturing Base and Competitors
Table 68. Crescita Therapeutics Inc. Major Business
Table 69. Crescita Therapeutics Inc. Semisolid Dosage Form Product and Services
Table 70. Crescita Therapeutics Inc. Semisolid Dosage Form Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 71. Mylan N.V. Basic Information, Manufacturing Base and Competitors
Table 72. Mylan N.V. Major Business
Table 73. Mylan N.V. Semisolid Dosage Form Product and Services
Table 74. Mylan N.V. Semisolid Dosage Form Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 75. Encore Dermatology, Inc. Basic Information, Manufacturing Base and Competitors
Table 76. Encore Dermatology, Inc. Major Business
Table 77. Encore Dermatology, Inc. Semisolid Dosage Form Product and Services
Table 78. Encore Dermatology, Inc. Semisolid Dosage Form Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 79. LEO Pharma Basic Information, Manufacturing Base and Competitors
Table 80. LEO Pharma Major Business
Table 81. LEO Pharma Semisolid Dosage Form Product and Services
Table 82. LEO Pharma Semisolid Dosage Form Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 83. Almirall, S.A Basic Information, Manufacturing Base and Competitors
Table 84. Almirall, S.A Major Business
Table 85. Almirall, S.A Semisolid Dosage Form Product and Services
Table 86. Almirall, S.A Semisolid Dosage Form Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 87. Aclaris Therapeutics, Inc. Basic Information, Manufacturing Base and Competitors
Table 88. Aclaris Therapeutics, Inc. Major Business
Table 89. Aclaris Therapeutics, Inc. Semisolid Dosage Form Product and Services
Table 90. Aclaris Therapeutics, Inc. Semisolid Dosage Form Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 91. Taro Pharmaceutical Industries Ltd. Basic Information, Manufacturing Base and Competitors
Table 92. Taro Pharmaceutical Industries Ltd. Major Business
Table 93. Taro Pharmaceutical Industries Ltd. Semisolid Dosage Form Product and Services
Table 94. Taro Pharmaceutical Industries Ltd. Semisolid Dosage Form Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 95. Teligent Pharma Basic Information, Manufacturing Base and Competitors
Table 96. Teligent Pharma Major Business
Table 97. Teligent Pharma Semisolid Dosage Form Product and Services
Table 98. Teligent Pharma Semisolid Dosage Form Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 99. Perrigo Pharma Basic Information, Manufacturing Base and Competitors
Table 100. Perrigo Pharma Major Business
Table 101. Perrigo Pharma Semisolid Dosage Form Product and Services
Table 102. Perrigo Pharma Semisolid Dosage Form Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 103. Global Semisolid Dosage Form Sales by Manufacturer (2019-2021e) & (Kiloton)
Table 104. Global Semisolid Dosage Form Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 105. Market Position of Manufacturers in Semisolid Dosage Form, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 106. Global Semisolid Dosage Form Production Capacity by Company, (Kiloton): 2020 VS 2021
Table 107. Head Office and Semisolid Dosage Form Production Site of Key Manufacturer
Table 108. Semisolid Dosage Form New Entrant and Capacity Expansion Plans
Table 109. Semisolid Dosage Form Mergers & Acquisitions in the Past Five Years
Table 110. Global Semisolid Dosage Form Sales by Region (2016-2021e) & (Kiloton)
Table 111. Global Semisolid Dosage Form Sales by Region (2021-2026) & (Kiloton)
Table 112. Global Semisolid Dosage Form Revenue by Region (2016-2021e) & (USD Million)
Table 113. Global Semisolid Dosage Form Revenue by Region (2021-2026) & (USD Million)
Table 114. Global Semisolid Dosage Form Sales by Type (2016-2021e) & (Kiloton)
Table 115. Global Semisolid Dosage Form Sales by Type (2021-2026) & (Kiloton)
Table 116. Global Semisolid Dosage Form Revenue by Type (2016-2021e) & (USD Million)
Table 117. Global Semisolid Dosage Form Revenue by Type (2021-2026) & (USD Million)
Table 118. Global Semisolid Dosage Form Price by Type (2016-2021e) & (US$/Ton)
Table 119. Global Semisolid Dosage Form Price by Type (2021-2026) & (US$/Ton)
Table 120. Global Semisolid Dosage Form Sales by Application (2016-2021e) & (Kiloton)
Table 121. Global Semisolid Dosage Form Sales by Application (2021-2026) & (Kiloton)
Table 122. Global Semisolid Dosage Form Revenue by Application (2016-2021e) & (USD Million)
Table 123. Global Semisolid Dosage Form Revenue by Application (2021-2026) & (USD Million)
Table 124. Global Semisolid Dosage Form Price by Application (2016-2021e) & (US$/Ton)
Table 125. Global Semisolid Dosage Form Price by Application (2021-2026) & (US$/Ton)
Table 126. North America Semisolid Dosage Form Sales by Country (2016-2021e) & (Kiloton)
Table 127. North America Semisolid Dosage Form Sales by Country (2021-2026) & (Kiloton)
Table 128. North America Semisolid Dosage Form Revenue by Country (2016-2021e) & (USD Million)
Table 129. North America Semisolid Dosage Form Revenue by Country (2021-2026) & (USD Million)
Table 130. North America Semisolid Dosage Form Sales by Type (2016-2021e) & (Kiloton)
Table 131. North America Semisolid Dosage Form Sales by Type (2021-2026) & (Kiloton)
Table 132. North America Semisolid Dosage Form Sales by Application (2016-2021e) & (Kiloton)
Table 133. North America Semisolid Dosage Form Sales by Application (2021-2026) & (Kiloton)
Table 134. Europe Semisolid Dosage Form Sales by Country (2016-2021e) & (Kiloton)
Table 135. Europe Semisolid Dosage Form Sales by Country (2021-2026) & (Kiloton)
Table 136. Europe Semisolid Dosage Form Revenue by Country (2016-2021e) & (USD Million)
Table 137. Europe Semisolid Dosage Form Revenue by Country (2021-2026) & (USD Million)
Table 138. Europe Semisolid Dosage Form Sales by Type (2016-2021e) & (Kiloton)
Table 139. Europe Semisolid Dosage Form Sales by Type (2021-2026) & (Kiloton)
Table 140. Europe Semisolid Dosage Form Sales by Application (2016-2021e) & (Kiloton)
Table 141. Europe Semisolid Dosage Form Sales by Application (2021-2026) & (Kiloton)
Table 142. Asia-Pacific Semisolid Dosage Form Sales by Region (2016-2021e) & (Kiloton)
Table 143. Asia-Pacific Semisolid Dosage Form Sales by Region (2021-2026) & (Kiloton)
Table 144. Asia-Pacific Semisolid Dosage Form Revenue by Region (2016-2021e) & (USD Million)
Table 145. Asia-Pacific Semisolid Dosage Form Revenue by Region (2021-2026) & (USD Million)
Table 146. Asia-Pacific Semisolid Dosage Form Sales by Type (2016-2021e) & (Kiloton)
Table 147. Asia-Pacific Semisolid Dosage Form Sales by Type (2021-2026) & (Kiloton)
Table 148. Asia-Pacific Semisolid Dosage Form Sales by Application (2016-2021e) & (Kiloton)
Table 149. Asia-Pacific Semisolid Dosage Form Sales by Application (2021-2026) & (Kiloton)
Table 150. South America Semisolid Dosage Form Sales by Country (2016-2021e) & (Kiloton)
Table 151. South America Semisolid Dosage Form Sales by Country (2021-2026) & (Kiloton)
Table 152. South America Semisolid Dosage Form Revenue by Country (2016-2021e) & (USD Million)
Table 153. South America Semisolid Dosage Form Revenue by Country (2021-2026) & (USD Million)
Table 154. South America Semisolid Dosage Form Sales by Type (2016-2021e) & (Kiloton)
Table 155. South America Semisolid Dosage Form Sales by Type (2021-2026) & (Kiloton)
Table 156. South America Semisolid Dosage Form Sales by Application (2016-2021e) & (Kiloton)
Table 157. South America Semisolid Dosage Form Sales by Application (2021-2026) & (Kiloton)
Table 158. Middle East & Africa Semisolid Dosage Form Sales by Country (2016-2021e) & (Kiloton)
Table 159. Middle East & Africa Semisolid Dosage Form Sales by Country (2021-2026) & (Kiloton)
Table 160. Middle East & Africa Semisolid Dosage Form Revenue by Country (2016-2021e) & (USD Million)
Table 161. Middle East & Africa Semisolid Dosage Form Revenue by Country (2021-2026) & (USD Million)
Table 162. Middle East & Africa Semisolid Dosage Form Sales by Type (2016-2021e) & (Kiloton)
Table 163. Middle East & Africa Semisolid Dosage Form Sales by Type (2021-2026) & (Kiloton)
Table 164. Middle East & Africa Semisolid Dosage Form Sales by Application (2016-2021e) & (Kiloton)
Table 165. Middle East & Africa Semisolid Dosage Form Sales by Application (2021-2026) & (Kiloton)
Table 166. Direct Channel Pros & Cons
Table 167. Indirect Channel Pros & Cons
Table 168. Semisolid Dosage Form Typical Distributors
Table 169. Semisolid Dosage Form Typical Customers
List of Figures
Figure 1. Semisolid Dosage Form Picture
Figure 2. Global Semisolid Dosage Form Sales Market Share by Type in 2020
Figure 3. Ointments
Figure 4. Pastes
Figure 5. Plasters
Figure 6. Gels
Figure 7. Rigid Foams
Figure 8. Global Semisolid Dosage Form Sales Market Share by Application in 2020
Figure 9. Skin
Figure 10. Nasal Cavity
Figure 11. Vaginal Cavity
Figure 12. Rectal Cavity
Figure 13. Others
Figure 14. Global Semisolid Dosage Form Market Size, (USD Million) & (Kiloton): 2020 VS 2021 VS 2026
Figure 15. Global Semisolid Dosage Form Market Size and Forecast (2016-2026) & (USD Million)
Figure 16. Global Semisolid Dosage Form Sales (2016-2026) & (Kiloton)
Figure 17. Global Semisolid Dosage Form Price by Type (2016-2026) & (US$/Ton)
Figure 18. Global Semisolid Dosage Form Production Capacity (2016-2026) & (Kiloton)
Figure 19. Global Semisolid Dosage Form Production Capacity by Geographic Region: 2020 VS 2021
Figure 20. Semisolid Dosage Form Market Drivers
Figure 21. Semisolid Dosage Form Market Restraints
Figure 22. Semisolid Dosage Form Market Trends
Figure 23. Global Semisolid Dosage Form Sales Market Share by Manufacturer in 2020
Figure 24. Global Semisolid Dosage Form Revenue Market Share by Manufacturer in 2020
Figure 25. Semisolid Dosage Form Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 26. Top 3 Semisolid Dosage Form Manufacturer (Revenue) Market Share in 2020
Figure 27. Top 6 Semisolid Dosage Form Manufacturer (Revenue) Market Share in 2020
Figure 28. Global Semisolid Dosage Form Sales Market Share by Region (2016-2026)
Figure 29. Global Semisolid Dosage Form Revenue Market Share by Region (2016-2026)
Figure 30. North America Semisolid Dosage Form Revenue (2016-2026) & (USD Million)
Figure 31. Europe Semisolid Dosage Form Revenue (2016-2026) & (USD Million)
Figure 32. Asia-Pacific Semisolid Dosage Form Revenue (2016-2026) & (USD Million)
Figure 33. South America Semisolid Dosage Form Revenue (2016-2026) & (USD Million)
Figure 34. Middle East & Africa Semisolid Dosage Form Revenue (2016-2026) & (USD Million)
Figure 35. Global Semisolid Dosage Form Sales Market Share by Type (2016-2026)
Figure 36. Global Semisolid Dosage Form Revenue Market Share by Type (2016-2026)
Figure 37. Global Semisolid Dosage Form Price by Type (2016-2026) & (US$/Ton)
Figure 38. Global Semisolid Dosage Form Sales Market Share by Application (2016-2026)
Figure 39. Global Semisolid Dosage Form Revenue Market Share by Application (2016-2026)
Figure 40. Global Semisolid Dosage Form Price by Application (2016-2026) & (US$/Ton)
Figure 41. North America Semisolid Dosage Form Sales Market Share by Type (2016-2026)
Figure 42. North America Semisolid Dosage Form Sales Market Share by Application (2016-2026)
Figure 43. North America Semisolid Dosage Form Sales Market Share by Country (2016-2026)
Figure 44. North America Semisolid Dosage Form Revenue Market Share by Country (2016-2026)
Figure 45. United States Semisolid Dosage Form Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Canada Semisolid Dosage Form Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Mexico Semisolid Dosage Form Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Europe Semisolid Dosage Form Sales Market Share by Type (2016-2026)
Figure 49. Europe Semisolid Dosage Form Sales Market Share by Application (2016-2026)
Figure 50. Europe Semisolid Dosage Form Sales Market Share by Country (2016-2026)
Figure 51. Europe Semisolid Dosage Form Revenue Market Share by Country (2016-2026)
Figure 52. Germany Semisolid Dosage Form Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. France Semisolid Dosage Form Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. United Kingdom Semisolid Dosage Form Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Russia Semisolid Dosage Form Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Italy Semisolid Dosage Form Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Asia-Pacific Semisolid Dosage Form Sales Market Share by Region (2016-2026)
Figure 58. Asia-Pacific Semisolid Dosage Form Sales Market Share by Application (2016-2026)
Figure 59. Asia-Pacific Semisolid Dosage Form Sales Market Share by Region (2016-2026)
Figure 60. Asia-Pacific Semisolid Dosage Form Revenue Market Share by Region (2016-2026)
Figure 61. China Semisolid Dosage Form Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Japan Semisolid Dosage Form Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Korea Semisolid Dosage Form Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. India Semisolid Dosage Form Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Southeast Asia Semisolid Dosage Form Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Australia Semisolid Dosage Form Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. South America Semisolid Dosage Form Sales Market Share by Type (2016-2026)
Figure 68. South America Semisolid Dosage Form Sales Market Share by Application (2016-2026)
Figure 69. South America Semisolid Dosage Form Sales Market Share by Country (2016-2026)
Figure 70. South America Semisolid Dosage Form Revenue Market Share by Country (2016-2026)
Figure 71. Brazil Semisolid Dosage Form Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Argentina Semisolid Dosage Form Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Middle East & Africa Semisolid Dosage Form Sales Market Share by Type (2016-2026)
Figure 74. Middle East & Africa Semisolid Dosage Form Sales Market Share by Application (2016-2026)
Figure 75. Middle East & Africa Semisolid Dosage Form Sales Market Share by Country (2016-2026)
Figure 76. Middle East & Africa Semisolid Dosage Form Revenue Market Share by Country (2016-2026)
Figure 77. Turkey Semisolid Dosage Form Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Egypt Semisolid Dosage Form Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Saudi Arabia Semisolid Dosage Form Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. South Africa Semisolid Dosage Form Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 81. Sales Channel: Direct Channel vs Indirect Channel
Figure 82. Methodology
Figure 83. Research Process and Data Source

---